MedTrace Logo

Effect of Vitamin D3 on Cardiovascular Risk Factors

NCT01501916 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-10-11

No results posted yet for this study

Summary

The aim of this study is to investigate whether a supplementation of Vitamin D3 can be used to reduce atherosclerotic risk factors.

Conditions

  • Hypertensive Disease
  • Deficiency of Vitamin D3

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

daily dosage of 50 µg Vitamin D3 for 8 weeks

DIETARY_SUPPLEMENT

Placebo

daily intake of placebo

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • Martin-Luther-Universität Halle-Wittenberg

    lead OTHER

Principal Investigators

  • Jutta Dierkes, Prof. Dr. · Institut für Agrar- und Ernährungswissenschaften

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-04-30
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501916 on ClinicalTrials.gov